Keiji Tasaka1, Katsutsugu Umeda1, Tatsuya Kamitori1, Hideto Ogata1, Takashi Mikami1, Itaru Kato1, Hidefumi Hiramatsu1, Yoshiki Arakawa2, Michio Noguchi3, Souichi Adachi4, Junko Takita1 (1.Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2.Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3.Medical Innovation center, Kyoto University Graduate School of Medicine, Kyoto, Japan, 4.Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan)
セッション情報
一般口演
第60回 日本小児血液・がん学会学術集会 » 一般口演
[_OS23] 一般口演23
脳腫瘍2
Oral Session 23 Brain tumor 2
2018年11月15日(木) 10:00 〜 11:20 第5会場 (みやこめっせ B1F 特別展示場B)
座長:清谷 知賀子(国立成育医療研究センター小児がんセンター), 橋井 佳子(大阪大学大学院医学系研究科小児科)
Daiki Yamashita1, Daichi Sajiki1, Ryo Maemura1, Ayako Yamamori1, Hirotoshi Sakaguchi1, Nao Yoshida1, Hisashi Hatano2, Hiroyuki Ogino3, Asahito Hama1 (1.Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 2.Department of Neurosurgery, Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 3.Department of Proton Therapy, Nagoya City West Medical Center, Aichi, Japan)
Ai Muroi, Eiichi Ishikawa, Akira Matsumura (Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan)
Naoki Tsuboya1, Junya Hirayama1, Takahide Kokumai1, Tomoki Hattori1, Takahiro Ito1, Norihito Mamiya1, Keishiro Amano1, Hidemi Toyoda1, Shotaro Iwamoto1, Hiroki Hori1, Akinori Takada2, Noriko Ii3, Masahiro Hirayama1 (1.Department of Pediatrics, Mie University Hospital, Mie, Japan, 2.Department of Radiation Oncology, Mie University Hospital, Mie, Japan, 3.Department of Radiation Oncology, Japanese Red Cross Ise Hospital, Mie, Japan)
Atsufumi Kawamura1, Akihiro Tamura2, Nobuyuki Yamamoto2, Kenji Kishimoto2, Toshiaki Ishida2, Daiichiro Hasegawa2, Yoshiyuki Kosaka2, Toshinori Soejima3 (1.Department of Neurosurgery, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan, 2.Department of Hematology and Oncology, Hyogo Prefectural Kobe Children’s Hospital Kobe, Japan, 3.Department of Radiation Oncology, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan)
Kazuyuki Komatsu1, Risa Makino1, Keisuke Urabe1, Koji Kawaguchi1, Takayuki Takachi1, Taemi Ogura1, Yasuo Horikoshi1, Hideto Iwafuchi2, Takafumi Wataya3, Ryuji Ishizaki3, Yuzuru Tashiro3, Kenichiro Watanabe1 (1.Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan, 2.Department of Pathology, Shizuoka Children’s Hospital, Shizuoka, Japan, 3.Department of Neurosurgery, Shizuoka Children’s Hospital, Shizuoka, Japan)
Maki Taniguchi1, Shuhei Karakawa1, Maiko Shimomura1, Yutaka Kato1, Hiroshi Kawaguchi1, Fumiyuki Yamasaki2, Masao Kobayashi1 (1.Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan, 2.Department of Neurosurgery, Hiroshima University Hospital, Hiroshima, Japan)
Naoki Kagawa1, Chisato Yokota1, Takamune Achiha1, Toru Umehara1, Hideyuki Arita1, Yasunori Fujimoto1, Haruhiko Kishima1 (1.Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan, 2.Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan)